Qube Research & Technologies Ltd Has $2.77 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Qube Research & Technologies Ltd cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 54.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 52,567 shares of the pharmacy operator’s stock after selling 63,635 shares during the quarter. Qube Research & Technologies Ltd’s holdings in Walgreens Boots Alliance were worth $2,766,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Stonebridge Capital Advisors LLC acquired a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $27,000. Loomis Sayles & Co. L P acquired a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $33,000. Red Door Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the 2nd quarter worth approximately $35,000. Centerpoint Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 203.8% during the 2nd quarter. Centerpoint Advisors LLC now owns 711 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 477 shares in the last quarter. Finally, Strategic Blueprint LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $38,000. Institutional investors and hedge funds own 55.65% of the company’s stock.

A number of equities research analysts have recently issued reports on the company. Credit Suisse Group reiterated a “hold” rating and set a $48.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, September 24th. Evercore ISI reiterated a “hold” rating and set a $52.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, July 2nd. Wolfe Research reiterated a “hold” rating and set a $57.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, July 2nd. Truist Securities dropped their price target on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a research note on Friday, July 2nd. Finally, Barclays dropped their price target on Walgreens Boots Alliance from $55.00 to $53.00 and set an “equal weight” rating on the stock in a research note on Tuesday, July 6th. Twelve investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $52.81.

WBA opened at $47.26 on Thursday. The firm has a market cap of $40.88 billion, a P/E ratio of 17.90, a price-to-earnings-growth ratio of 1.41 and a beta of 0.49. Walgreens Boots Alliance, Inc. has a 52-week low of $33.36 and a 52-week high of $57.05. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.53 and a current ratio of 0.77. The business’s fifty day moving average is $48.70 and its 200-day moving average is $50.83.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

Recommended Story: What are momentum indicators and what do they show?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.